Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
letter
. 2014 Oct;58(10):6333–6334. doi: 10.1128/AAC.03601-14

Characterization of Environmental CTX-M-15-Producing Stenotrophomonas maltophilia

Ana Maravić a, Mirjana Skočibušić a,, Željana Fredotović a, Svjetlana Cvjetan b,c, Ivica Šamanić a, Jasna Puizina a
PMCID: PMC4187975  PMID: 25092701

LETTER

Stenotrophomonas maltophilia is a widespread environmental microorganism (1) that has emerged as a significant opportunistic pathogen (2) due to its intrinsic resistance to almost all available antibiotics. Apart from native β-lactamases L1 and L2 (1), acquired extended-spectrum β-lactamases (ESBLs) were also identified (3, 4), pointing to S. maltophilia as a potential reservoir. Furthermore, resistance to trimethoprim-sulfamethoxazole (SXT), a therapy of choice for S. maltophilia, is being increasingly reported (58).

Forty-one S. maltophilia isolates were recovered from retail shellfish (Mytilus galloprovincialis; 8 isolates) purchased at fish markets in Split, Croatia, and from coastal marine waters near Split (33 isolates) in 2012. Strains were isolated on imipenem (16 μg/ml)-containing tryptic soy agar at 30°C and identified using API 20NE.

Whole-cell DNA was extracted and used for PCR detection of ESBL genes (9). Nineteen isolates carried blaCTX-M-15, six of which additionally harbored blaTEM-116, and one carried blaTEM-127 (Table 1). Metallo-β-lactamase genes were not detected (10). TEM-116 is usually associated with environmental Enterobacteriaceae (11) and Pseudomonas spp. (12) and has never before been identified in S. maltophilia. More importantly, CTX-M-15 was previously identified only in an S. maltophilia clinical strain from France (4). S1 nuclease pulsed-field gel electrophoresis (PFGE) of plasmid DNA followed by Southern blotting (9) showed that blaCTX-M-15 was located on large plasmids of various sizes (Table 1). Conjugation transfer of blaCTX-M-15 using Escherichia coli J53 (13) at 37°C and 27°C and using azide (100 μg/ml) and cefotaxime (8 μg/ml)-containing Luria-Bertani agar failed even after repeated attempts. Only a 160-kb plasmid (isolate 248) was successfully transferred into E. coli JM109 using heat shock transformation. For PCR-based replicon typing (14), plasmid DNA from the transformant was used, while for other isolates, each plasmid band was cut from the gel and, after confirmation as blaCTX-M-15 positive by PCR, was used as a template. Interestingly, all plasmids belonged to the IncFIB incompatibility group. IncFII, IncFIA, and IncFIB blaCTX-M-15-bearing plasmids have been previously reported in Croatia (9, 15). A possible explanation for the unusual lack of IncF plasmid replication in E. coli recipients could be that plasmids adapted to S. maltophilia, altering their host range and specificity of replication traits (16). Further studies are needed to better characterize these resistance plasmids.

TABLE 1.

Isolation data and resistance determinants of ESBL-producing and SXT-resistant S. maltophilia isolates

Isolate Origin Isolation datea β-Lactamase(s) identified Size of CTX-M-15-bearing plasmid (kb) Size(s) of other plasmid(s) (kb) MIC of SXT (μg/ml) int gene sul gene(s) Gene cassette
122 Mussel 06/01/2012 CTX-M-15 200 50 >64 sul2
123 Mussel 05/15/2012 CTX-M-15 200 50 >64 sul2
124 Mussel 07/04/2012 CTX-M-15 160 40 0.5
125 Mussel 09/05/2012 CTX-M-15 160 100 0.5
126 Mussel 09/26/2012 CTX-M-15 200 >64 int1 sul1 dfrA17-aadA5
138 Seawater 07/04/2012 CTX-M-15 160 7 0.25
159 Seawater 07/04/2012 CTX-M-15 160 >64 int1 sul1
165 Seawater 12/05/2012 CTX-M-15 200 7, 30 >64 int1 sul1
166 Seawater 11/14/2012 CTX-M-15 160 40 0.5 int1 aacA4
167 Seawater 09/05/2012 CTX-M-15 160 50 >64 int1 sul1, sul2 dfrA17-aadA5
168 Seawater 06/15/2012 CTX-M-15 80 7 >64 int1 sul2 dfrA17-aadA5
203 Seawater 06/15/2012 CTX-M-15, TEM-116 100 >64 int1 dfrA17-aadA5
204 Seawater 06/01/2012 CTX-M-15, TEM-116 160 7, 70 >64 int1 sul1 cmlA1
208 Seawater 05/16/2012 CTX-M-15, TEM-116 160 7 >64 sul2
209 Seawater 06/01/2012 CTX-M-15, TEM-116 160 7 1 int1 cmlA1
210 Seawater 01/20/2012 CTX-M-15, TEM-116 160 7 1 int1 cmlA1
211 Seawater 03/01/2012 TEM-127 0.5 int1 aacA4
218 Seawater 09/05/2012 CTX-M-15, TEM-116 250 30 0.5 int1 catB2
247 Mussel 06/15/2012 CTX-M-15 160 7 >64 int1 sul1
248 Seawater 11/14/2012 CTX-M-15 160 50 >64 int1 sul1, sul2 dfrA17-aadA5
a

Isolation dates are shown as month/day/year.

PFGE of XbaI-digested genomic DNA (17, 18) showed heterogeneity among CTX-M-15-producing isolates (data not shown). Isolates were further investigated for class 1, 2, and 3 integrases, gene cassettes, and the sul1 and sul2 genes by PCR (7, 8). Class 1 integron gene cassettes were amplified using primers 5′CS and 3′CS (7) and then sequenced and analyzed using BLAST. SXT MICs, assessed by Etest (19), ranged from 0.25 to >64 μg/ml. In combination with dfrA and sul2, sul1 may lead to high resistance to SXT in S. maltophilia (8). Of 12 SXT-resistant isolates, 9 were class 1 integrase positive and 7 possessed sul1; 2 isolates carried sul1 and sul2 (Table 1). Previously, sul1 was identified in clinical isolates from China, Taiwan, Europe, and the Americas (58). It is noteworthy that the dfrA17-aadA5 gene cassette has previously been detected only in clinical isolates from China (8).

This report presents the first description of IncF::CTX-M-15 in S. maltophilia isolates of environmental and clinical origins and of SXT resistance traits previously found only in clinical isolates, emphasizing the possibility that S. maltophilia isolates are hidden reservoirs for these multidrug resistance determinants.

ACKNOWLEDGMENTS

We thank António Correia (University of Aveiro, Portugal) for providing E. coli J53.

This work was supported by the Ministry of Science, Education and Sports, Croatia (grants 177-0000000-3182 and 177-1191196-0829).

Footnotes

Published ahead of print 4 August 2014

REFERENCES

  • 1.Brooke JS. 2012. Stenotrophomonas maltophilia: an emerging global opportunistic pathogen. Clin. Microbiol. Rev. 25:2–41. 10.1128/CMR.00019-11 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Falagas ME, Kastoris AC, Vouloumanou EK, Rafailidis PI, Kapaskelis AM, Dimopoulos G. 2009. Attributable mortality of Stenotrophomonas maltophilia infections: a systematic review of the literature. Future Microbiol. 4:1103–1109. 10.2217/fmb.09.84 [DOI] [PubMed] [Google Scholar]
  • 3.al Naiemi N, Duim B, Bart A. 2006. A CTX-M extended-spectrum beta-lactamase in Pseudomonas aeruginosa and Stenotrophomonas maltophilia. J. Med. Microbiol. 55:1607–1608. 10.1099/jmm.0.46704-0 [DOI] [PubMed] [Google Scholar]
  • 4.Lavigne J-P, Gaillard J-B, Bourg G, Tichit C, Lecaillon E, Sotto A. 2008. Étude de souches de Stenotrophomonas maltophilia sécrétrices de BLSE: détection de CTX-M et étude de la virulence. Pathol. Biol. 56:447–453. 10.1016/j.patbio.2008.07.013 [DOI] [PubMed] [Google Scholar]
  • 5.Barbolla R, Catalano M, Orman BE, Famiglietti A, Vay C, Smayevsky J, Centrón D, Piñeiro SA. 2004. Class I integrons increase trimethoprim-sulfamethoxazole MICs against epidemiologically unrelated Stenotrophomonas maltophilia isolates. Antimicrob. Agents Chemother. 48:666–669. 10.1128/AAC.48.2.666-669.2004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Toleman MA, Bennett PM, Bennett DMC, Jones RN, Walsh TR. 2007. Global emergence of trimethoprim/sulfamethoxazole resistance in Stenotrophomonas maltophilia mediated by acquisition of sul genes. Emerg. Infect. Dis. 13:559–565. 10.3201/eid1304.061378 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Liaw S-J, Lee Y-L, Hsueh P-R. 2010. Multidrug resistance in clinical isolates of Stenotrophomonas maltophilia: roles of integrons, efflux pumps, phosphoglucomutase (SpgM), and melanin and biofilm formation. Int. J. Antimicrob. Agents 35:126–130. 10.1016/j.ijantimicag.2009.09.015 [DOI] [PubMed] [Google Scholar]
  • 8.Hu L-F, Chang X, Ye Y, Wang Z-X, Shao Y-B, Shi W, Li X, Li J-B. 2011. Stenotrophomonas maltophilia resistance to trimethoprim/sulfamethoxazole mediated by acquisition of sul and dfrA genes in a plasmid-mediated class 1 integron. Int. J. Antimicrob. Agents 37:230–234. 10.1016/j.ijantimicag.2010.10.025 [DOI] [PubMed] [Google Scholar]
  • 9.Maravić A, Skočibušić M, Šamanić I, Fredotović Ž, Cvjetan S, Jutronić M, Puizina J. 2013. Aeromonas spp. simultaneously harbouring blaCTX-M-15, blaSHV-12, blaPER-1 and blaFOX-2, in wild-growing Mediterranean mussel (Mytilus galloprovincialis) from Adriatic Sea, Croatia. Int. J. Food Microbiol. 166:301–308. 10.1016/j.ijfoodmicro.2013.07.010 [DOI] [PubMed] [Google Scholar]
  • 10.Poirel L, Walsh TR, Cuvillier V, Nordmann P. 2011. Multiplex PCR for detection of acquired carbapenemase genes. Diagn. Microbiol. Infect. Dis. 70:119–123. 10.1016/j.diagmicrobio.2010.12.002 [DOI] [PubMed] [Google Scholar]
  • 11.Machado E, Coque TM, Canton R, Sousa JC, Silva D, Ramos M, Rocha J, Ferreira H, Peixe L. 2009. Leakage into Portuguese aquatic environments of extended-spectrum-β-lactamase-producing Enterobacteriaceae. J. Antimicrob. Chemother. 63:616–618. 10.1093/jac/dkn510 [DOI] [PubMed] [Google Scholar]
  • 12.Maravić A, Skočibušić M, Šamanić I, Puizina J. 2012. Antibiotic susceptibility profiles and first report of TEM extended-spectrum β-lactamase in Pseudomonas fluorescens from coastal waters of the Kaštela Bay, Croatia. World J. Microb. Biotechnol. 28:2039–2045. 10.1007/s11274-012-1006-5 [DOI] [PubMed] [Google Scholar]
  • 13.Tacão M, Moura A, Correia A, Henriques I. 2014. Co-resistance to different classes of antibiotics among ESBL-producers from aquatic systems. Water Res. 48:100–107. 10.1016/j.watres.2013.09.021 [DOI] [PubMed] [Google Scholar]
  • 14.Carattoli A, Bertini A, Villa L, Falbo V, Hopkins KL, Threlfall EJ. 2005. Identification of plasmids by PCR-based replicon typing. J. Microbiol. Methods 63:219–228. 10.1016/j.mimet.2005.03.018 [DOI] [PubMed] [Google Scholar]
  • 15.Literacka E, Bedenic B, Baraniak A, Fiett J, Tonkic M, Jajic-Bencic I, Gniadkowski M. 2009. blaCTX-M genes in Escherichia coli strains from Croatian hospitals are located in new (blaCTX-M-3a) and widely spread (blaCTX-M-3a and blaCTX-M-15) genetic structures. Antimicrob. Agents Chemother. 53:1630–1635. 10.1128/AAC.01431-08 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Carattoli A. 2009. Resistance plasmid families in Enterobacteriaceae. Antimicrob. Agents Chemother. 53:2227–2238. 10.1128/AAC.01707-08 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Berg G, Roskot N, Smalla K. 1999. Genotypic and phenotypic relationships between clinical and environmental isolates of Stenotrophomonas maltophilia. J. Clin. Microbiol. 37:3594–3600 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Tenover FC, Arbeit RD, Goering VR, Mickelsen PA, Murray BE, Pershing DH, Swaminathan B. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233–2239 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Clinical and Laboratory Standards Institute. 2012. Performance standards for antimicrobial susceptibility testing. CLSI M100-S22 Clinical and Laboratory Standards Institute, Wayne, PA [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES